Key Features

  • Brain region quantification
  • Brain volume changes
  • Report generation

General Information

Product name

icobrain dm

Company

Subspeciality

Neuro

Modality

CT, MR

Disease targeted

Dementia

Main task

Not specified

Technical Specifications

Population

MCI, dementia, Alzheimer's, FTD, DLB, ...

Patient population age

Not specified

Input

For MRI: 3D T1 weighted image

Input format

DICOM

Output

Color-coded segmentation overlays, concise reports with reference statistics, pre-populated radiological reporting template

Output format

DICOM

Integration

Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform

Deployment

Cloud-based

Trigger for analysis

Automatically, Etc., Image upload, On demand, Right after the image acquisition, Triggered by a user through e.g. a button click

Processing time

> 10 minutes

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register
FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

2018

AI Platforms

Bayer Pharmaceuticals, Blackford Analysis, GE Healthcare, Intrasense, Nuance

Resellers

Not specified

Countries present

23

Paying clinical customers

>100

Research/test users

>300

Pricing Information

Pricing model

Subscription

Based on

Number of analyses

Evidence & Research

Peer-Reviewed Papers

Peer-Reviewed

View

Automated Volumetric Software in Dementia: Help or Hindrance to the Neuroradiologist?

Peer-Reviewed

View

Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer’s disease diagnosis

Peer-Reviewed

View

Combining semi-quantitative rating and automated brain volumetry in MRI evaluation of patients with probable behavioural variant of fronto-temporal dementia: an added value for clinical practise?

Peer-Reviewed

View

Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm

Peer-Reviewed

View

Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s Disease in a Clinical Setting: A REMEMBER Study

Source: vendor | First published: May 26, 2024 | Last updated: Jul 9, 2025